DAVOS, May 27: Pfizer Inc has launched ‘An Accord for a Healthier World’, an initiative aimed at providing all of Pfizer’s patented, high-quality medicines and vaccines available in the US or the European Union on a not for-profit basis to 1.2 billion people in 45 lower-income countries.

WASHINGTON, Nov 6: Pfizer Inc. said that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.

UNITED STATES, Nov 10: Pfizer Inc's PFE.N experimental COVID-19 vaccine is more than 90% effective based on initial trial results, the drugmaker said on Monday, a major victory in the war against a virus that has killed over a million people and battered the world's economy.